tiprankstipranks
Trending News
More News >
Laboratorios Farmaceuticos Rovi, SA (ES:ROVI)
BME:ROVI
Spanish Market

Laboratorios Farmaceuticos Rovi (ROVI) Financial Statements

Compare
37 Followers

Laboratorios Farmaceuticos Rovi Financial Overview

Laboratorios Farmaceuticos Rovi's market cap is currently €3.46B. The company's EPS TTM is €1.134; its P/E ratio is 28.90; and it has a dividend yield of 1.50%. Laboratorios Farmaceuticos Rovi is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 763.75M€ 829.51M€ 817.70M€ 648.68M€ 419.96M
Gross Profit€ 478.35M€ 483.34M€ 519.61M€ 384.82M€ 241.31M
Operating Income€ 179.54M€ 220.25M€ 255.85M€ 181.57M€ 74.68M
EBITDA€ 207.69M€ 245.81M€ 281.49M€ 204.72M€ 93.28M
Net Income€ 136.88M€ 170.34M€ 199.67M€ 153.08M€ 61.06M
Balance Sheet
Cash & Short-Term Investments€ 27.41M€ 25.32M€ 124.94M€ 99.03M€ 53.16M
Total Assets€ 832.02M€ 799.88M€ 878.70M€ 732.68M€ 574.44M
Total Debt€ 114.41M€ 65.43M€ 72.14M€ 73.14M€ 73.52M
Net Debt€ 87.22M€ 40.10M€ -52.81M€ -25.89M€ 20.36M
Total Liabilities€ 250.48M€ 256.39M€ 357.32M€ 261.70M€ 200.74M
Stockholders' Equity€ 572.03M€ 539.39M€ 520.01M€ 470.98M€ 373.70M
Cash Flow
Free Cash Flow€ 76.06M€ 58.06M€ 186.21M€ 108.50M€ 7.18M
Operating Cash Flow€ 138.28M€ 113.25M€ 237.60M€ 149.44M€ 46.88M
Investing Cash Flow€ -81.06M€ -52.03M€ -57.15M€ -40.84M€ -39.63M
Financing Cash Flow€ -55.36M€ -160.84M€ -154.54M€ -62.73M€ -21.52M
Currency in EUR

Laboratorios Farmaceuticos Rovi Earnings and Revenue History

Laboratorios Farmaceuticos Rovi Debt to Assets

Laboratorios Farmaceuticos Rovi Cash Flow

Laboratorios Farmaceuticos Rovi Forecast EPS vs Actual EPS